Cargando…
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
Apurinic/apyrimidinic endonuclease 1 (APE1), which has the dual functions of both DNA repair and redox activity, has been reported to be highly expressed in non-small cell lung cancer (NSCLC), and this appears to be a characteristic related to chemotherapy resistance. In this study, we identified se...
Autores principales: | Dai, Nan, Cao, Xiao-Jing, Li, Meng-Xia, Qing, Yi, Liao, Ling, Lu, Xian-Feng, Zhang, Shi-Heng, Li, Zheng, Yang, Yu-Xin, Wang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589448/ https://www.ncbi.nlm.nih.gov/pubmed/23472128 http://dx.doi.org/10.1371/journal.pone.0058001 |
Ejemplares similares
-
Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients
por: Zhang, Shiheng, et al.
Publicado: (2016) -
From APE to APE-100: present and future of the APE project
por: Bacilieri, P, et al.
Publicado: (1988) -
MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma
por: Liang, Wei, et al.
Publicado: (2017) -
Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021) -
Apes
por: Lowenstine, Linda J., et al.
Publicado: (2018)